The FDA approved a new epinephrine nasal spray called neffy as an alternative to the EpiPen for treating anaphylaxis. The nasal spray is designed for adults and children over 30 kg, using a compound called Intravail to enhance absorption. It is expected to be more affordable than the EpiPen, with a two-pack priced at $199 or less. Additionally, the CDC raised slightly its risk assessment for the H5N1 bird flu virus, while Berkeley, California implemented a healthy checkout policy to promote healthier food choices. There is ongoing advocacy for stronger warning labels on alcohol products and a reminder to be cautious of rabies during the summer months.
Source link
Getting healthier in the checkout aisle and the alcohol aisle
